Physician profile
Danielle Emery
NPI 1174294862
$12,355.40
in general payments reported to CMS, 2019-2025
48 companies · $2,448 in 2025
The $2,448 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $639 · 2022: $3,177 · 2023: $3,423 · 2024: $2,669 · 2025: $2,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,472 · Education: $67.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,472.37 |
| Education | $67.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,321.73 | 2021-2025 | |
| Lilly USA, LLC | $1,209.26 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Xeris Pharmaceuticals, INC. | $1,154.22 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Sanofi-Aventis U.S. LLC | $791.73 | 2021-2025 | |
| Abbott Laboratories | $620.88 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Tandem Diabetes Care, INC. | $576.04 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astrazeneca Pharmaceuticals LP | $550.52 | 2021-2024 | Farxiga |
| Novo Nordisk INC | $537.02 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Dexcom, INC. | $513.03 | 2022-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Corcept Therapeutics | $451.39 | 2021-2024 | Korlym |
| Novartis Pharmaceuticals Corporation | $445.83 | 2022-2025 | |
| Amgen INC. | $416.19 | 2021-2025 | Repatha, Tepezza, Repatha |
| Astellas Pharma US INC | $313.38 | 2023-2025 | Veozah |
| Beta Bionics, INC. | $286.17 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Radius Health, INC. | $286.16 | 2021-2025 | Tymlos |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $271.30 | 2024-2025 | Teriparatide |
| Horizon Therapeutics Plc | $249.99 | 2023 | Tepezza |
| Recordati_rare_diseases_inc. | $227.34 | 2023-2025 | Isturisa, Signifor Lar |
| Abbvie INC. | $208.25 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $194.49 | 2022-2023 | Hetlioz, Fanapt |
| Ascendis Pharma Endocrinology INC | $166.69 | 2025 | Yorvipath |
| Amneal Pharmaceuticals LLC | $153.87 | 2022-2025 | Unithroid |
| Madrigal Pharmaceuticals | $141.54 | 2024-2025 | Rezdiffra, Resmetirom |
| Insulet Corporation | $122.13 | 2024-2025 | Omnipod |
| Averitas Pharma INC. | $118.41 | 2023-2024 | Qutenza |
| Lifescan, INC. | $94.10 | 2022 | |
| Neurocrine Biosciences, INC. | $78.58 | 2024-2025 | |
| Cequr Corporation | $77.88 | 2021 | |
| Esperion Therapeutics, INC. | $72.25 | 2021-2025 | Nexletol |
| Amarin Pharma, INC. | $69.57 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $65.40 | 2023-2024 | Evkeeza |
| Medtronic, INC. | $62.13 | 2023 | Minimed 780g |
| Mannkind Corporation | $62.07 | 2022-2023 | Afrezza |
| Ibsa Pharma INC. | $62.06 | 2022-2024 | Tirosint, Licart |
| Grt US Holding, INC. | $54.58 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $45.57 | 2022-2023 | Crysvita |
| Aimmune Therapeutics, INC. | $43.13 | 2024-2025 | Zenpep |
| Sequel Med Tech, LLC | $40.30 | 2025 | Twiist |
| Kyowa Kirin, INC. | $25.30 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.56 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.09 | 2023 | Synjardy, Jardiance |
| Zealand Pharma US, INC. | $23.28 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $20.61 | 2024 | |
| Nevro Corp. | $20.10 | 2024 | Senza |
| Vivus LLC | $19.91 | 2025 | Pancreaze |
| Kowa Pharmaceuticals America, INC. | $14.89 | 2022 | |
| Nestle Healthcare Nutrition INC. | $14.06 | 2022 | |
| Currax Pharmaceuticals LLC | $13.42 | 2024 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Emery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.